Jeff Farrow

Track

Insider profile

Currently holds a position at Global Blood Therapeutics Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 37% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Global Blood Therapeutics Inc April 4, 2016 -
Jeff Farrow's trades of Tarsus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-16
S Sale
32,645 -41.4%
341.56
US$1,594,474 		32,645 -41.4% 341.56 US$1,594,474
2026-06-16 2026-06-16
PrS Proposed sale
1,425
460.86
US$1,215,788 		1,425 460.86 US$1,215,788
2026-03-19 2026-03-19
S Sale
1,132 +11.2%
240.69
US$3,397,314 		1,132 +11.2% 240.69 US$3,397,314
2026-03-19 2026-03-19
PrS Proposed sale
2,186
67.00
US$146,459 		2,186 67.00 US$146,459
2026-03-19 2026-03-18
S Sale
2,133 -4.5%
68.71
US$146,558 		2,133 -4.5% 68.71 US$146,558
2026-03-18 2026-03-18
PrS Proposed sale
2,133
68.71
US$146,558 		2,133 68.71 US$146,558
2026-03-19 2026-03-17
S Sale
2,111 -4.2%
69.42
US$146,546 		2,111 -4.2% 69.42 US$146,546
2026-03-17 2026-03-17
PrS Proposed sale
2,111
69.41
US$146,534 		2,111 69.41 US$146,534
2025-06-18 2025-06-17
S Sale
13,608 -27.0%
40.42
US$550,035 		13,608 -27.0% 40.42 US$550,035
2025-06-17 2025-06-17
PrS Proposed sale
13,608
40.42
US$550,088 		13,608 40.42 US$550,088
2025-03-20 2025-03-20
PrS Proposed sale
1,186
50.11
US$59,435 		1,186 50.11 US$59,435
2025-03-20 2025-03-20
S Sale
1,186 -5.0%
50.11
US$59,430 		1,186 -5.0% 50.11 US$59,430
2025-03-20 2025-03-19
S Sale
1,254 -5.0%
47.40
US$59,440 		1,254 -5.0% 47.40 US$59,440
2025-03-19 2025-03-19
PrS Proposed sale
1,254
47.40
US$59,439 		1,254 47.40 US$59,439
2025-03-20 2025-03-18
S Sale
1,284 -4.9%
46.29
US$59,436 		1,284 -4.9% 46.29 US$59,436
2025-03-18 2025-03-18
PrS Proposed sale
1,284
46.28
US$59,429 		1,284 46.28 US$59,429
2024-06-20 2024-06-18
S Sale
10,445 -36.5%
27.47
US$286,924 		10,445 -36.5% 27.47 US$286,924
2024-06-18 2024-06-18
PrS Proposed sale
10,445
27.47
US$286,966 		10,445 27.47 US$286,966
2022-09-06 2022-09-01
S Sale
31,441 -91.1%
68.00
US$2,137,988 		31,441 -91.1% 68.00 US$2,137,988
2020-07-15 2020-07-13
PlS Planned sale
15,208 -83.3%
75.00
US$1,140,600 		15,208 -83.3% 75.00 US$1,140,600
2020-06-11 2020-06-09
PlS Planned sale
15,208 -45.4%
67.00
US$1,018,936 		15,208 -45.4% 67.00 US$1,018,936